Key result
Primary cardiac synovial sarcoma is a rare malignancy requiring ancillary diagnostic procedures, such as identifying the t(X;18) translocation, for definitive diagnosis.
Why the study?
Primary cardiac synovial sarcoma is a rare malignant neoplasm with diagnostic challenges requiring ancillary procedures for confirmation.
Primary cardiac synovial sarcoma is a rare malignancy that requires advanced molecular and immunohistochemical techniques, particularly the identification of the t(X;18) translocation, for definitive diagnosis.
Prompts molecular testing in cardiac spindle-cell tumors; leaves open standardized diagnostic and outcome registries.
Primary cardiac synovial sarcoma is an uncommon malignant neoplasm, with only a handful of cases reported in the English literature to date. Synovial sarcomas have also been described at other unusual sites, such as the heart, pleuropulmonary region, kidney, prostate, liver, mediastinum, retroperitoneum, gastrointestinal tract, and peripheral nerve. For synovial sarcomas that arise at these unusual locations, definitive diagnosis is challenging and requires use of ancillary diagnostic procedures, such as immunohistochemistry, electron microscopy, and molecular genetic techniques, for confirmation of diagnosis. The nonrandom occurrence of t(X;18) has been found consistently in synovial sarcomas. It has also been found as a sole cytogenetic abnormality in some cases, suggesting it as a key molecular event in tumor development. This review highlights salient features of primary cardiac synovial sarcoma and the associated diagnostic challenges.
No takes yet. Share an insight, caveat, or question.
Varma et al. (2012) conducted a review in Primary cardiac synovial sarcoma. Primary cardiac synovial sarcoma is a rare malignancy requiring ancillary diagnostic procedures, such as identifying the t(X;18) translocation, for definitive diagnosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: